President Trump Extends Most Favored Nation Drug Pricing to All Medicaid Programs, Citing Significant Price Reductions
President Trump has announced the extension of Most Favored Nation (MFN) drug pricing to every Medicaid program across the United States. This initiative aims to significantly reduce prescription drug costs for Americans, building on previous efforts by the administration. According to the White House, this expansion means that all 50 states, the District of Columbia, and Puerto Rico will now benefit from MFN pricing, which is projected to unlock nearly $65 billion in Medicaid drug savings over the next decade. The administration claims that this move will provide substantial relief for low-income families, children, seniors, and individuals with disabilities, while also benefiting taxpayers. President Trump stated that prescription drug prices have recorded their sharpest annual drop in over 60 years, with prices falling every month of 2026, attributing this success to his policies.
